Gregory della Penna
Internal Medicine · New Orleans, LANPI 1336700822
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,260 of the $5,243 with a category attached, or 62.2%. 32 manufacturers reported payments, led by Sanofi at 24.0% of the total. 2025 is the largest year on record at $2,248, 2.1 times the $1,072 reported in 2022.
Across 161 payments — averaging $32.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$1K
- Regeneron$1K
- AstraZeneca$393
- Takeda Pharmaceuticals U.S.A., Inc.$347
- Regeneron Healthcare Solutions, Inc.$297
- GSK$294
- plus $2K from 26 others
What the payments were for
- Consulting fees$481%
- Grants$1,80034%
- Food & beverage$3,26062%
- Education$1363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 13 | $1,259 |
| Regeneron | 1 | $1,000 |
| AstraZeneca | 22 | $393 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $347 |
| Regeneron Healthcare Solutions, Inc. | 16 | $297 |
| GSK | 14 | $294 |
| Amgen | 9 | $174 |
| CSL Behring | 5 | $154 |
| Grifols USA, LLC | 5 | $149 |
| Novartis | 7 | $138 |
| Hospira, Inc. | 5 | $96 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $92 |
| Genentech USA, Inc. | 5 | $81 |
| Lilly USA, LLC | 4 | $76 |
| Biocryst US Sales Co., LLC | 4 | $69 |
| Hikma Pharmaceuticals USA | 4 | $68 |
| Ionis Pharmaceuticals, Inc. | 2 | $67 |
| Sanofi-aventis U.S. LLC | 1 | $55 |
| Pfizer | 3 | $54 |
| Azurity Pharmaceuticals, Inc. | 3 | $53 |
| Pharming Healthcare, Inc. | 3 | $52 |
| AbbVie | 2 | $50 |
| ADMA Biomanufacturing LLC | 2 | $48 |
| Cycle Pharmaceuticals Inc | 2 | $34 |
| Seqirus USA Inc | 1 | $22 |
| GC Biopharma USA, Inc. | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $16 |
| LEO Pharma Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$216
How this compares
$5,243 in reported general payments places this provider in the 85th percentile of 1,528 internal medicine providers in Louisiana.
Other internal medicine in New Orleans
- Steven DeitelzweigNew Orleans$939K
- Daniel EnglertNew Orleans$74K
- Jordan GrahamNew Orleans$25K
- Pavan ChavaNew Orleans$24K
- Susan KaramNew Orleans$22K
- Arti ThanguduNew Orleans$20K
- David BrownNew Orleans$17K
- Peter PantlinNew Orleans$13K
- Genevieve MarongeNew Orleans$12K
- Samiullah ArshadNew Orleans$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.